5VM

5AM Venture Management Portfolio holdings

AUM $260M
1-Year Return 3.76%
This Quarter Return
-28.61%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$264M
AUM Growth
-$155M
Cap. Flow
-$8.53M
Cap. Flow %
-3.23%
Top 10 Hldgs %
63.89%
Holding
32
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

1
SRZN icon
Surrozen
SRZN
+$3.61M

Top Sells

1
ELVN icon
Enliven Therapeutics
ELVN
+$6.05M
2
AKRO icon
Akero Therapeutics
AKRO
+$4.59M
3
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
+$1.51M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TRDA icon
1
Entrada Therapeutics
TRDA
$192M
$39.9M 15.07%
4,408,379
– –
ELVN icon
2
Enliven Therapeutics
ELVN
$1.1B
$26M 9.84%
1,322,477
-307,288
-19% -$6.05M
DNTH icon
3
Dianthus Therapeutics
DNTH
$1.47B
$18.6M 7.05%
1,027,711
– –
SKYE icon
4
Skye Bioscience
SKYE
$126M
$15.8M 5.96%
9,913,168
– –
PHVS icon
5
Pharvaris
PHVS
$1.5B
$12.5M 4.74%
797,600
– –
CNTA
6
Centessa Pharmaceuticals
CNTA
$2.95B
$11.9M 4.52%
830,945
– –
CAMP icon
7
CAMP4 Therapeutics Corporation Common Stock
CAMP
$53.4M
$11.7M 4.43%
2,927,915
– –
BHVN icon
8
Biohaven
BHVN
$1.45B
$11.5M 4.35%
478,972
– –
MLTX icon
9
MoonLake Immunotherapeutics
MLTX
$3.38B
$11M 4.17%
282,313
– –
VRDN icon
10
Viridian Therapeutics
VRDN
$1.47B
$9.93M 3.76%
736,595
– –
TECX
11
Tectonic Therapeutic, Inc. Common Stock
TECX
$310M
$9.06M 3.43%
511,660
-85,000
-14% -$1.51M
CLDX icon
12
Celldex Therapeutics
CLDX
$1.63B
$9.03M 3.41%
497,270
– –
TYRA icon
13
Tyra Biosciences
TYRA
$656M
$8.74M 3.3%
939,298
– –
ERAS icon
14
Erasca
ERAS
$454M
$7.41M 2.8%
5,405,404
– –
ARTV
15
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$57.4M
$7.06M 2.67%
2,353,304
– –
ANAB icon
16
AnaptysBio
ANAB
$564M
$6.65M 2.52%
357,733
– –
PRAX icon
17
Praxis Precision Medicines
PRAX
$851M
$6.44M 2.43%
170,000
– –
GHRS icon
18
GH Research
GHRS
$813M
$6.32M 2.39%
572,665
– –
EYPT icon
19
EyePoint Pharmaceuticals
EYPT
$924M
$5.69M 2.15%
1,050,000
– –
VKTX icon
20
Viking Therapeutics
VKTX
$2.71B
$4.58M 1.73%
189,593
– –
VOR icon
21
Vor Biopharma
VOR
$203M
$4.56M 1.73%
6,361,723
– –
SRZN icon
22
Surrozen
SRZN
$99.8M
$3.61M 1.37%
+310,000
New +$3.61M
TARA icon
23
Protara Therapeutics
TARA
$122M
$3.41M 1.29%
800,000
– –
SCPH icon
24
scPharmaceuticals
SCPH
$301M
$3.16M 1.19%
1,200,647
– –
RLYB icon
25
Rallybio
RLYB
$24.8M
$2.38M 0.9%
3,630,724
– –
1
2